Search Results 1331-1340 of 18649 for hepatitis

1. Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple Myeloma - Mayo Clinic

   Negative hepatitis B test (defined by a negative test for hepatitis B surface antigen [HBsAg], or antibodies to hepatitis B surface and/or core antigens ...

2. immunizations Archives - Mayo Clinic News Network

   hepatitis B shortly after birth. Infants should receive these vaccines between 1 and 2 months of age: Diphtheria, tetanus and whooping cough (pertussis) ...

3. Immunizations — Stop Sickness Before It Starts - Mayo Clinic News Network

   Cassingham. “By getting a vaccine, you are protecting everyone who works and lives around you as well.” Hepatitis C ...

4. A Study To Confirm the Effectiveness and Safety of Terlipressin in Adults with Hepatorenal Syndrome Type 1 - Mayo Clinic

   ... hepatitis, or toxins (e.g., Amanita toxin with mushroom poisoning carbon tetrachloride), with the exception of acute alcoholic hepatitis. Proteinuria ...

5. A Study to Evaluate MEDI2228 in Subjects with Relapsed/ Refractory Multiple Myeloma - Mayo Clinic

   ... hepatitis C virus (HCV) infections at the time of screening which are defined as: Positive hepatitis B surface antigen (HBsAg) or positive hepatitis B core ...

6. Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients with ALS - Mayo Clinic

   Positive test for Hepatitis B, Hepatitis C, HIV. Current use of immunosuppressant medication or use of such medication within 4 weeks of Screening visit ...

7. A Study of New Outcome Measures to Assess the Progression of Amyotrophic Lateral Sclerosis - Mayo Clinic

   History of or a positive test result at screening for hepatitis C virus (HCV) antibody or hepatitis B virus (HBV); Possibility of neuromuscular weakness ...

8. Efficacy and Safety of Seralutinib in Adult Subjects With PAH - Mayo Clinic

   Evidence of active or latent Human immunodeficiency virus (HIV), Hepatitis B or Hepatitis C, or tuberculosis (TB) infection at Screening. 20. Prior ...

9. Pemigatinib to Treat Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations - Mayo Clinic

   Evidence of active hepatitis B (HBV) or hepatitis C (HCV) infection. Other known active malignancy < 5 years prior to registration. EXCEPTIONS: Non ...

10. Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma - Mayo Clinic

    Known active hepatitis B (e.g., hepatitis B surface antigen [HBsAg] reactive) or hepatitis C (e.g., hepatitis C virus [HCV] ribonucleic acid [RNA] [qualitative] ...